A hidden process inside brain cells may reveal new clues about how the disease begins and what comes next with new research.

For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...

The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...

Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...

The 76-year-old journalist went public with his diagnosis last month, saying his first symptom was “forgetting people’s names ...

Valiltramiprosate, a drug in development as a disease-modifying therapy for Alzheimer’s disease, showed rapid and sustained ...

Readers respond to a Science Times article, “New Potential for Diagnosing Alzheimer’s Disease.” Also: The noise that data centers make.

People who lived within 50 km of a coal-fired power plant were 72.9% more likely to develop Alzheimer’s disease pathology ...

Bill Ritter spoke with doctors at Columbia about Alzheimer's disease and their groundbreaking research.

New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.

In 3,895 older adults, moderate daytime cortisol variability was associated with better cognition and slower decline, while ...

How can Alzheimer's research be made faster, better, and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully ...